Skip to NavigationSkip to content

GlaxoSmithKline opens new £56 million facility in Hertfordshire

Published on 19/04/16 at 09:17am

GlaxoSmithKline has opened a new £56 million manufacturing facility in Hertfordshire, South-East England.

The facility in Ware will create 150 new jobs and will form the new base for the pharma giant’s production of inhalers to use with respiratory medicines. Chief executive of GSK, Sir Andrew Witty, and life sciences minister, George Freeman MP, were given a tour of the facility which produces the Ellipta inhalers.

This is the latest investment in the Ware facility which formed part of a £200 million investment by GSK into its UK facilities.

Witty says: “This new facility demonstrates our commitment to manufacturing in the UK which continues to be a very positive environment for life sciences investment. We currently export Ellipta inhalers from Ware to over 74 countries and the new facility opened today will increase capacity to meet growing demand for our new portfolio of respiratory medicines worldwide.”

Freeman added: “This £56 million investment by GSK is fantastic news for Ware and the UK’s thriving life sciences industry.”

Sean Murray

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches